Save information for later
Sign Up

Learn About Epilepsy Juvenile Absence

What is the definition of Epilepsy Juvenile Absence?
Juvenile absence epilepsy (JAE) is a genetic epilepsy with onset occurring around puberty. JAE is characterized by sporadic occurrence of absence seizures, frequently associated with a long-life prevalence of generalized tonic-clonic seizures (GTCS) and sporadic myoclonic jerks.
What are the alternative names for Epilepsy Juvenile Absence?
  • Epilepsy juvenile absence
  • Childhood absence epilepsy
  • JAE
  • Juvenile absence epilepsy
Who are the top Epilepsy Juvenile Absence Local Doctors?
Elite in Epilepsy Juvenile Absence
Elite in Epilepsy Juvenile Absence

Yale University

800 Howard Ave, 
New Haven, CT 
Languages Spoken:
English

Hal Blumenfeld is a Neurologist in New Haven, Connecticut. Dr. Blumenfeld and is rated as an Elite provider by MediFind in the treatment of Epilepsy Juvenile Absence. His top areas of expertise are Absence Seizure, Seizures, Epilepsy Juvenile Absence, Epilepsy, and Deep Brain Stimulation.

Terrance P. Snutch
Elite in Epilepsy Juvenile Absence
Elite in Epilepsy Juvenile Absence
Vancouver, BC, CA 

Terrance Snutch practices in Vancouver, Canada. Mr. Snutch and is rated as an Elite expert by MediFind in the treatment of Epilepsy Juvenile Absence. His top areas of expertise are Epilepsy Juvenile Absence, Sporadic Hemiplegic Migraine, Absence Seizure, and Migraine with Brainstem Aura.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Epilepsy Juvenile Absence
Elite in Epilepsy Juvenile Absence
Nijmegen, GE, NL 

Gilles Van Luijtelaar practices in Nijmegen, Netherlands. Mr. Van Luijtelaar and is rated as an Elite expert by MediFind in the treatment of Epilepsy Juvenile Absence. His top areas of expertise are Epilepsy Juvenile Absence, Absence Seizure, Epilepsy, Seizures, and Deep Brain Stimulation.

What are the latest Epilepsy Juvenile Absence Clinical Trials?
A Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study With a 2 Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Summary: The purpose of the study is to test the efficacy, safety and tolerability of brivaracetam monotherapy in study participants 2 to 25 years of age inclusive with childhood absence epilepsy (CAE) or juvenile absence epilepsy (JAE).

Match to trials
Find the right clinical trials for you in under a minute
Get started
A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY

Summary: The purpose of the study is to investigate the long-term safety and tolerability of brivaracetam in study participants with childhood absence epilepsy or juvenile absence epilepsy.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center